MTI-301 for the Treatment of Metastatic or Unresectable and Refractory Solid Cancers

Clinical trial NCT06911008 · RECRUITING

Trial details

NCT number: NCT06911008
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Malignant Solid Neoplasm Refractory Malignant Solid Neoplasm Unresectable Malignant Solid Neoplasm

Start date: 2025-11-07
Primary completion: 2027-04-09
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.